Plant genetic engineering to fight ‘hidden hunger’

Scienmag

Agriculture Agricultural Production/Economics Biology Biotechnology Food/Food Science Genetics Molecular Biology Nutrition/Nutrients Plant Sciences

#news #biotech Restoring eyesight with genetically engineered stem cells

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Restoring eyesight with genetically engineered stem cells.Restoring eyesight with genetically engineered stem cells arlene.weintraub Mon, 11/30/2020 – 09:46 from FierceBiotech: Biotech [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use

The Pharma Data

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S.

#news #biotech Plant genetic engineering to fight hidden hunger

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Plant genetic engineering to fight hidden hunger.More than 2 billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins.

Genetic engineering without unwanted side effects helps fight parasites

Scienmag

Around a third of the world’s population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb. The single-celled pathogen also leads to economic losses in agriculture, with toxoplasmosis increasing the risk of abortion among sheep, for example. The parasite has a complex […].

#news #biotech Genetic engineering without unwanted side effects helps fight parasites

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genetic engineering without unwanted side effects helps fight parasites.Modified CRISPR-Cas9 gene editing scissors are enabling researchers at the University of Zurich to make alterations to the genetic … Continue reading → #news

Genetically engineered T cells could lead to therapies for autoimmune diseases

Scienmag

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments. Medicine & Health Biotechnology cancer Cell Biology Gene Therapy Genetics Immunology/Allergies/Asthma Medicine/Health

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

Is China Using CRISPR to Create Super Soldiers?

BioSpace

Has China discovered a super-soldier formula through the capabilities of genetic engineering? A U.S. government official claims this is exactly what is happening

Cataloging nature’s hidden arsenal: Viruses that infect bacteria

Scienmag

And despite the numerous clever drugs and genetic engineering […]. Biology Bacteriology Genetics Microbiology Virology

#news #biotech Can a miniscule worm hold the secret to genetically reversing brain damage?

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Can a miniscule worm hold the secret to genetically reversing brain damage? A team of Hebrew University researchers have successfully used genetic engineering as a first step to … Continue reading → #news

Molecule holds promise to reprogram white blood cells for better cancer treatment

Scienmag

In this type of therapy, T cells, a type of white blood cell, are collected from a patient’s blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) […].

Biotech cotton key to eliminating devastating pest from US and Mexico

Scienmag

A multifaceted strategy combining genetically engineered cotton with classical pest control tactics eradicated the pink bollworm from […]. For much of the past century, the invasive pink bollworm wreaked havoc in the southwestern United States and northern Mexico — inflicting tens of millions of dollars in damage annually to cotton on both sides of the border.

CIBMTR Completes Enrollment in Yescarta® Long-Term Post-Marketing Safety Study, 2 Years Ahead of Schedule

BioTech 365

Synergy between biotech and classical control tactics rid US of invasive pest

Scienmag

Credit: Agricultural Research Service-USDA.

Flipping light on-off turns bacteria into chemical factories

Scienmag

Credit: Avalos Lab/Princeton University Researchers at Princeton University have created a new and improved way to more precisely control genetically engineered bacteria: by simply switching the lights on and off.

Rubius Therapeutics Presents Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers, Demonstrating its Dual Mechanism of Action

BioTech 365

Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an … Continue reading → GlobeNewswireRTX-321 Induces Antigen-Specific Stimulation Combined with Broad Stimulation of Innate and Adaptive Immune Responses CAMBRIDGE, Mass., 28, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc.

$3.9M project on self-deleting genes takes aim at mosquito-borne diseases

Scienmag

Texas A&M AgriLife researchers’ work to aid mosquito control efforts To control mosquito populations and prevent them from transmitting diseases such as malaria, many researchers are pursuing strategies in mosquito genetic engineering. A new Texas A&M AgriLife Research project aims to enable temporary “test runs” of proposed genetic changes in mosquitoes, after which the changes […].

COVID-19 lung damage caused by persistence of ‘abnormal cells’

Scienmag

The study, published today in The Lancet’s eBioMedicine, by King’s College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may […]. Investigations of deceased COVID-19 patients have shed light on possible lung damage caused by the virus.

Golden meat: Engineering cow cells to produce beta carotene

Scienmag

Scientists prove cell-cultured meat products can offer enhanced nutrition compared to conventionally produced meat A group of researchers at Tufts University have genetically engineered cow muscle cells to produce plant nutrients not natively found in beef cells.

Genetic Vaccine Development for Infectious Diseases Summit

Pharma Phorum

A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality, but our future. The post Genetic Vaccine Development for Infectious Diseases Summit appeared first on.

Taconic Biosciences Expands Immuno-oncology Animal Model PortfolioCritical Jh Syngeneic Tumor Model Host Now Available on a B6 Background

The Pharma Data

These models are engrafted with mouse tumors derived from the same strain background; this genetic similarity between tumor and host prevents the host from rejecting the tumor. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services.

PlateletBio Names Dr. Steven Altschuler as Chairman of its Board of Directors

The Pharma Data

Its cell therapy platform produces “platelet-like cells” (PLCs) capable of performing vital biological functions and able to be genetically engineered into multiple allogeneic therapies. 28, 2021 12:30 UTC. WATERTOWN, Mass.–(

Johns Hopkins Researchers Identify CRISPR Dimmer

The Pharma Data

But altering the tracr-L with genetic engineering to make it function more like a guide RNA increased CRISPR-Cas9 cuts.

AI-designed serotonin tracker could help develop neurology drugs

Pharma Phorum

Tian’s lab builds on the work of scientists in the lab of Dr Loren Looger, Howard Hughes Medical Institute Janelia Research Campus, Ashburn, Virginia, who used traditional genetic engineering techniques to convert the bacterial protein into a sensor of the neurotransmitter acetylcholine.

South African variant may cut response from Pfizer/BioNTech shot, study finds

Pharma Phorum

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

2nd Macrophage-directed Therapies Summit

Pharma Phorum

billion acquisition of Forty Seven by Gilead is an example of the explosive excitement and investment into macrophage-directed therapies, utilizing CD47 checkpoint blockades, repolarization approaches and engineered macrophages, that we have witnessed in recent months.

Could Fluoride be the Solution to Antibiotic Resistance? A New Study Weighs In

The Pharma Data

The UC Santa Barbara research uses a method that addresses not only antibiotic overuse, but also the containment of genetically modified organisms (GMOs). “If

AstraZeneca-Oxford COVID-19 Vaccine Shows High Efficacy

XTalks

Developed by researchers at the University of Oxford, the COVID vaccine is an adenovirus vector-based vaccine derived from chimpanzees that contains a genetically engineered virus that causes the common cold in chimpanzees, along with the spike protein of the SARS-CoV-2 coronavirus.

NHS and Kite sign access deal for Kite’s cancer cell therapy Tecartus

Pharma Phorum

CAR-T therapies are made by harvesting a patient’s T-cells, genetically engineering them to target cancer cells and reintroducing them into the body. NHS patients in England will be among the first in the world to receive Gilead’s Tecartus cancer cell therapy for certain types of lymphoma, after the company’s specialist Kite unit struck a deal with NICE. .

In the precision medicine era, the line between products and services is blurred

Pharma Phorum

The treatments are developed using cutting- edge technologies such as genomic sequencing and genetic engineering, helping to account for the individual variability in both patient and disease characteristics.

Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners

The Pharma Data

At Elasmogen we have been able to capture, using the latest protein and genetic engineering techniques, the immune system of 10,000 shark equivalents in a test-tube.

Novartis’ Ilaris fails in late-stage COVID-19 trial

Pharma Phorum

Novartis is also working with Molecular Partners to develop therapies based on genetically engineered proteins known as DARPins. Novartis’ Ilaris (canakinumab) has failed to produce results in a phase 3 trial, which tested whether it could improve COVID-19 patients’ survival chances without need for mechanical ventilation.

Good Gut Bacteria Can Aid in Healing Intestines Damaged by IBD

XTalks

The study developed and researched microbe-controlled and genetically-engineered mice to understand the healing response in the intestine when receiving specific signals from bacteria.

Clinical Catch-Up: January 4-8 | BioSpace

The Pharma Data

ILP100 is a genetically engineered Lactobacillus that acts as a small bioreactor on site in the wound, continuously introducing a chemokine, CXCL12, into the wound tissue. The new year began with a fairly low level of clinical trial news. Here’s a look. COVID-19-Related.

Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineAdvance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate

The Pharma Data

NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. GAITHERSBURG, Md., 16, 2020 (GLOBE NEWSWIRE) — Novavax , Inc.

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

The Pharma Data

NVX-CoV2373 is a vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. GAITHERSBURG, Md., 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc.

Targovax announces formation of new Scientific Advisory Board

The Pharma Data

Dr. Zamarin’s clinical and laboratory research are focused on characterization of biomarkers in patients undergoing immunotherapy and on development of novel immunotherapeutic strategies using immunomodulatory antibodies and genetically-engineered oncolytic viruses.

Novavax Announces COVID-19 Vaccine Clinical Development Progress

The Pharma Data

CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix?M. GAITHERSBURG, Md., 30, 2020 (GLOBE NEWSWIRE) — Novavax, Inc.

COVID-19 Vaccines Currently Being Developed and What It All Mean for Us

Riverside Clinical Research

There are also genetically engineered vaccines which use RNA and DNA to copy the S protein in hopes of. There is no question that humankind requires assistance…a heavy-hitter, a formidable opponent to help. combat COVID-19. An effective vaccine is exactly that shot in the arm we need to protect ourselves. against this deadly pandemic. So, that begs the question, “Where are we in the process of COVID-19. vaccine development?”.

Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech Innovation Forum on a COVID-19 Panel

The Pharma Data

These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality. SAN JOSE, Calif. ,

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides. . LAVAL, QC, Nov. 5, 2020 /PRNewswire/ – Crescita Therapeutics Inc.

Biopharma Leaders Unite To Stand With Science

The Pharma Data

Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.